75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Nature of Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Property and Equipment , net link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Convertible loan notes and equity classified warrants link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Warrant Liability link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Other Income/(expenses) , Net link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Revenue and Cost of Revenue link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Share Based Compensation link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Related Party Disclosures link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Segment information link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Property and Equipment , net (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Warrant Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Share Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Segment information (Tables) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Fair Value Measurement (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Fair Value Measurement - Schedule of financial assets and liabilities measured at fair value on a recurring basis (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses And Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Prepaid expenses and other current assets (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Property and Equipment , net - Summary of Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Property and Equipment , net - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Intangible Assets (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Leases (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Leases - Weighted Average Remaining Lease Term and Discount Rate (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Leases - Cash Paid for Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Leases - Schedule of Maturities of Operating lease liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Leases - Schedule of Maturities of Operating lease liabilities (Details) 2 link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Other current liabilities - Schedule of Other current liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Other current liabilities (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Convertible loan notes and equity classified warrants (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Warrant Liability - Summary of change in fair value of the warrant liability (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Warrant Liability - Summary of weighted average inputs to the models used for the fair value of warrants (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Warrant Liability (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Shareholders' Equity - Summary of Common Shares (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Shareholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Other income/(expenses) , net (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Income Taxes (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Income Taxes - Summary of Components of Loss before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Income Taxes - Summary of Components of Income Tax Expense (Details) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Income Taxes - Summary of Reconciliation of U.K Statutory Income Tax Rate to Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Income Taxes - Summary of Components of the Company's Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Income Taxes - Summary of Movements in Deferred Tax Valuation Allowance (Details) link:presentationLink link:calculationLink link:definitionLink 996115 - Disclosure - Revenue and Cost of revenue (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996125 - Disclosure - Share Based Compensation (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996135 - Disclosure - Share Based Compensation - Summary of Share Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 996145 - Disclosure - Share Based Compensation - Summary of Option Activity and Related Information (Details) link:presentationLink link:calculationLink link:definitionLink 996155 - Disclosure - Share Based Compensation - Summary of Assumptions used in Black-Scholes Option Pricing Model (Details) link:presentationLink link:calculationLink link:definitionLink 996165 - Disclosure - Share Based Compensation - Summary of Restricted Stock Unit Activity and Related Information (Details) link:presentationLink link:calculationLink link:definitionLink 996175 - Disclosure - Share Based Compensation - Summary of Performance Based Restricted Stock Unit (PSUs) Activity and Related Information (Details) link:presentationLink link:calculationLink link:definitionLink 996185 - Disclosure - Loss per Share - Schedule of Weighted Average Number of Ordinary Shares Outstanding and The Effect of Dilutive Ordinary Share (Details) link:presentationLink link:calculationLink link:definitionLink 996195 - Disclosure - Loss per Share - Schedule of Potentially Dilutive Shares Were Not Included In The Calculation of Diluted Shares Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 996205 - Disclosure - Commitments and Contingencies (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996215 - Disclosure - Related Party Disclosures (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996225 - Disclosure - Subsequent Events (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996235 - Disclosure - Segment information - Schedule of Financial Data for the Company's Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink Deferred consideration liability Deferred Consideration Liability Current Deferred consideration liability Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted average per share fair value of options, vesting Weighted average per share fair value of options, vesting Expected Life of Share Options Granted Expected Life of Share Options Granted Expected life (years) Market Value Options Market Value Options [Member] Market Value Options [Member] Setrusumab (BPS-804/UX143) [Member] Setrusumab (BPS-804/UX143) [Member] Entity Incorporation, State or Country Code Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Plan Name [Axis] Equity [Abstract] Entity Current Reporting Status Proceeds from Warrant Exercises Proceeds from exercise of warrants Increase (Decrease) in Deferred Liabilities Deferred Liabilities, Total Deferred Liabilities, Total Fair Value, Inputs, Level 2 [Member] Level 2 Deferred Tax Assets, Net of Valuation Allowance Net deferred tax assets Net deferred tax assets Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Document Fiscal Period Focus Reduced Cash Payments Reduced cash payments Reduced Cash Payments Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate Entity Shell Company Contractual Obligation Manufacturing commitments Contractual Obligation, Total Convertible Debt [Member] Convertible Debt Instrument [Member] Cash and Cash Equivalent Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Effective Income Tax Rate Reconciliation, Permanent Differences Effective Income Tax Rate Reconciliation, Permanent Differences Permanent differences Share Based Compensation Arrangement By Share Based Payment Award Fair Value of Vested And Delivered Share Based Compensation Arrangement By Share Based Payment Award Fair Value of Vested And Delivered Fair value of vested and delivered Conversion of convertible loan notes, shares Stock Issued During Period, Shares, Conversion of Units Common Stock, Shares, Issued Ordinary stock, shares issued Statement [Table] Share-Based Payment Arrangement, Disclosure [Abstract] Statement [Line Items] Business Combination [Domain] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired Warrants to purchase ordinary shares Warrant liabilities Warrant [Member] Entity Filer Category Liabilities and Equity Total liabilities and shareholders' equity Debt Instrument [Line Items] Payables and Accruals [Abstract] Long-Lived Tangible Asset [Axis] Share Based Compensation Arrangement by Share Based Payment Award Options, Vested, Weighted Average Fair Value Share Based Compensation Arrangement by Share Based Payment Award Options, Vested, Weighted Average Fair Value Weighted Average Exercise Fully Vested Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Increase/(decrease in valuation allowance) Operating Loss Carryforwards [Table] Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents (investments in money market funds) Deferred Tax Assets, Valuation Allowance Valuation allowance at December 31 Valuation allowance at January 1 Valuation allowance Valuation allowance Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Income tax using U.K. statutory rate Subsequent Event [Line Items] Effective Income Tax Rate Reconciliation, Percent Effective tax rate for income from continuing operations Effective Income Tax Rate Reconciliation, Percent, Total Income Tax Rate Options Convertibale loan notes Convertible Debt Securities [Member] Classes Of Share Capital Axis Classes Of Share Capital Axis Investment Income, Interest Interest income Income Tax Authority [Axis] Geographical [Domain] Payments to Acquire Intangible Assets Purchase of intangible assets Payments for intangible assets Additional paid-in capital Additional Paid in Capital, Common Stock Deferred Tax Assets, Property, Plant and Equipment Property and equipment Property, Plant and Equipment [Line Items] Vesting [Domain] Issuance Of Common Stock Transaction Costs Not Yet Paid Issuance Of Common Stock Transaction Costs Not Yet Paid Issuance of ordinary shares - transaction costs not yet paid Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted Share-Based Payment Arrangement [Member] Earnings Per Share, Basic Loss per share - basic Earnings Per Share, Basic, Total Net loss per share - basic Payments Made Under License Agreement Payments Made Under License Agreement Payments made under license agreement Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent Adjustments in respect of prior years Novartis Pharma [Member] Novartis Pharma [Member] Novartis Pharma [Member] Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Other comprehensive (loss)/income - Foreign currency translation adjustments, net of tax Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of Options, Ending Balance Number of Options, Begining Balance Class Of Warrants Domain Class Of Warrants Domain Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Weighted Average Exercise Fully Vested Finite-Lived Intangible Assets Acquired Intangible assets acquired Liabilities, Current Ending for the period Beginning for the period Total current liabilities Proceeds from Sale of Equity Securities, FV-NI Proceeds from Sale of Equity Securities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Convertible Notes Payable, Noncurrent Convertible loan notes - non-current Domestic Tax Authority [Member] Federal Tax Authority [Member] Consolidation Items [Domain] Equity, Attributable to Parent [Abstract] Shareholders' Equity Entity Small Business Retained Earnings (Accumulated Deficit) Accumulated deficit Retained Earnings (Accumulated Deficit), Total Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Share and stock options Share based compensation awards Alvelestat (MPH-966) [Member] Alvelestat (MPH-966) [Member] Value Added Tax Receivable, Current VAT receivable Nature of Operations [Text Block] Nature of Business Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Forfeited Forfeited Share-Based Payment Arrangement [Text Block] Share Based Compensation Lessee, Operating Lease, Liability, to be Paid, Rolling Year Two 2026 Nature Of Business Abstract Nature Of Business Abstract Nature of business [Abstract] Leases [Abstract] Cash paid for amounts included in the measurement of lease liabilities: Amendment Flag Loss Contingencies [Line Items] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants Convertible in Equity Entity Address, Postal Zip Code Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Increase (Decrease) in Operating Lease Liability Operating lease liabilities Ordinary Shares Common Stock [Member] Common Shares Tax Credit Carryforward, Amount Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less: accumulated depreciation Other Operating Income (Expense), Net Other segment items Stock Issued During Period, Shares, Performance Share Unit, Vesting Stock Issued During Period, Shares, Performance Share Unit, Vesting Vesting of PSUs Shares Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Effective Interest Rate Entity Address, Address Line One Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Assumptions used in Black-Scholes Option Pricing Model Fair Value Hierarchy and NAV [Axis] Earnings Per Share [Abstract] Supplemental Cash Flow Information [Abstract] Supplemental disclosure Schedule of Prepaid Expenses And Other Current Assets Schedule of Prepaid Expenses And Other Current Assets [Table Text Block] Schedule of Prepaid Expenses and Other Current Assets Deferred Tax Assets, State Taxes US tax credits Section 174 R&E Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period, Intrinsic Value Expired Operating lease right of use assets, net Operating Lease, Right-of-Use Asset Operating right of use assets recognized Deferred Tax Assets, Gross Gross deferred tax asset Gross deferred tax asset Gross deferred tax asset Document Type Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Stock Issued During Period, Shares, Period Increase (Decrease) Issuance of ordinary shares, shares Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Entity Central Index Key Exercise of warrants cost Exercise of warrants cost Exercise of warrants value Exercise of warrants, value Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Decrease in cash and cash equivalents Subsequent Event Type [Domain] Fair Value Adjustment of Warrants Change in fair value of warrants Warrants Subscribed [Member] Warrants Subscribed Member Warrants Subscribed Interest income Interest Income, Operating Interest Income, Operating, Total Non-cash interest income Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Common Stock, Par or Stated Value Per Share Ordinary stock, par value Security Deposit Security deposits Operating costs and expenses Operating Costs and Expenses Operating Costs and Expenses, Total Indefinitely Expired [Member] Indefinitely Expired [Member] Liabilities [Abstract] Liabilities Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of operating lease right-of-use assets Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average contractual life of options, outstanding Prepaid research and development services Prepaid research and development services Prepaid research and development expenses Effective income tax rate enacted tax rate Effective Income Tax Rate Enacted Tax Rate Enacted Statutory Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercise of share options, shares Share options exercised in the quarter Exercised Other Prepaid Expense, Current Other assets Debt Disclosure [Abstract] Options Vesting [Member] Options Vesting [Member] Options Vesting [Member] Warrant Liability Warrant Liability Warrant liability , Ending Period Warrant liability , Beginning Period Warrant Liability Accrued Liabilities, Current Accrued expenses Accrued Liabilities, Current, Total Delivery of shares on vesting of restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Vesting of RSUs, value Current Fiscal Year End Date Schedule of Long-Term Debt Instruments [Table] Uk Tax Authority [Member] Uk Tax Authority [Member] Document Quarterly Report Other Accrued Liabilities Other accrued expenses Convertible Notes Payable Convertible loan notes - current Convertible Notes Payable, Total Amount of Convertible Note Fair Value, by Balance Sheet Grouping [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of RSUs, Ending Balance Number of RSUs, Beginning Balance Warrant Liability Foreign Exchange Warrant Liability Foreign Exchange Foreign exchange American Depositary Shares [Member] American Depositary Shares [Member] American Depositary Shares Financial Liabilities Fair Value Disclosure Financial Liabilities Fair Value Disclosure, Total Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive loss Classes Of Financial Instruments Domain Classes Of Financial Instruments Domain Geographical [Axis] Us Tax Authority [Member] Us Tax Authority [Member] Stock Issued During Period, Value, Stock Options Exercised Exercise of share options, value Share options exercised in the quarter Exercise of share options, value Exercise of share options, value Performance stock units Performance Based Restricted Stock Units Performance Shares [Member] Subsequent Event [Member] Subsequent Event [Member] Uncertain tax position Uncertain Tax Position Uncertain tax position After Amendments [Member] After Amendments [Member] After Amendments [Member] Property, Plant and Equipment [Abstract] Antidilutive Securities [Axis] Operating Loss Carryforwards [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Expired Expired Basis of Presentation and Significant Accounting Policies [Text Block] Basis Of Presentation And Summary Of Significant Accounting Policies Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Fair value of vested U.S. federal [Member] U.S. federal [Member] Explanation Of Changes In Applicable Tax Rates To Previous Accounting Period Explanation Of Changes In Applicable Tax Rates To Previous Accounting Period Applicable Tax Rates To Previous Accounting Period Interest Expense, Debt Debt, Interest Expense Interest Expense, Debt, Total Other Commitments [Domain] State and Local Jurisdiction [Member] State and Local Jurisdiction Tax Authority [Member] Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Summary of Share Based Compensation Related Party Transaction [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Prepaid General and Administrative Expenses Prepaid General and Administrative Expenses Prepaid general and administrative expenses Beginning Treasury Stock Common Balance ,Shares Treasury Stock, Common, Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Cash and Cash Equivalents [Domain] Deferred Tax Asset, Debt Securities, Non Trading Deferred Tax Asset, Debt Securities, Non Trading Temporary differences non trading Temporary differences non trading Two Thousand Twenty Novartis Warrants [Member] Two Thousand Twenty Novartis Warrants [Member] 2020 Novartis Warrants Debt Instrument, Maturity Date Debt Instrument, Maturity Date Minimum [Member] Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Deferred Tax Assets and Liabilities, Percent Deferred Tax Assets and Liabilities, Percent Deferred Tax Assets and Liabilities, Measured Rate Assets, Current [Abstract] Current assets: Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss Temporary differences trading Temporary differences trading Class of Warrant or Right, Number of Securities Called by Each Warrant or Right warrants exercised Amortization of Intangible Assets Amortization Of Intangible Assets Amortization of intangible assets Amortization of intangible assets Fair Value, Inputs, Level 3 [Member] Level 3 Market Price of Ordinary Shares Market Price of Ordinary Shares Market value of Ordinary Shares Segment Reporting [Abstract] Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Liabilities, Current [Abstract] Current liabilities: Percentage Of Issued Shares Capital Percentage Of Issued Shares Capital Percentage Of Issued Shares Capital Schedule of other current liabilities Other Current Liabilities [Table Text Block] Related Party Transactions [Abstract] Shares, Outstanding Ending balance, shares Beginning balance, shares Operating Loss Carryforwards Operating Loss Carryforwards Other Income Other income Other income Commitments and contingencies (Note 16) Commitments and Contingencies Deferred Compensation, Share-Based Payments [Member] Share-based compensation awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Ending Balance Weighted Average Grant Date Fair Value, Beginning Balance Unvested weighted average grant date fair value Operating Lease, Liability Operating lease liabilities - current Lease Liability Expire In 2024 [Member] Expire In 2024 [Member] Two Thousand And Nineteen Equity Incentive Plan [Member] Mereo Two Thousand And Nineteen Equity Incentive Plan [Member] 2019 Equity Incentive Plan [Member] Gain (Loss) on Derivative Instruments, Net, Pretax Gain (Loss) on Derivative Instruments, Net, Pretax, Total Changes in the fair value of warrants Exercise of warrants Exercise of warrants Exercise of warrants shares Exercise of warrants, shares Lessee, Lease, Description [Table] ReproNovo Partnership [Member] ReproNovo Partnership [Member] ReproNovo Partnership Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Changes in deferred tax valuation allowance Long-Term Debt, Type [Domain] Loss Contingencies [Table] Weighted Average Number of Shares Outstanding, Basic Weighted average shares outstanding - basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted-average number of shares used in computing net loss per share - basic Deferred Tax Liabilities, Right of Use Assets Deferred Tax Liabilities, Right of Use Assets Right-of-use assets Document Information [Line Items] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Novartis Loan Note [Member] Novartis Loan Note [Member] Novartis Loan Note [Member] Deferred Tax Liabilities, Leasing Arrangements Right-of-use assets Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Tax Losses Carried Forward Tax Losses Carried Forward Tax Losses carry forward Long-Lived Tangible Asset [Domain] Deferred Tax Assets, Net [Abstract] Deferred tax assets: Subsequent Events [Text Block] Subsequent Events Rule10b51 Arr Modified Flag Rule 10b5-1 Arrangement Modified [Flag] Rule 10b5-1 Arrangement Modified Related Party Disclosures Related Party Transactions Disclosure [Text Block] APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Deferred Tax Assets, in Process Research and Development Section 174 R&E US tax credits Equity, Attributable to Parent Ending balance, value Beginning balance, value Cost Total shareholders' equity Basis of presentation Basis of Accounting, Policy [Policy Text Block] Statement of Stockholders' Equity [Abstract] Classes Of Financial Instruments Axis Classes Of Financial Instruments Axis Delivery of Shares on Vesting of Performance Based Restricted Stock Units Value Delivery of Shares on Vesting of Performance Based Restricted Stock Units Value Delivery of Shares on Vesting of Performance Based Restricted Stock Units, Value Cash Equivalents [Member] Other Liabilities Disclosure [Abstract] Use of Estimates, Policy [Policy Text Block] Use of estimates Treasury Shares Treasury Stock, Common [Member] Non Rule10b51Arr Modified Flag Non-Rule 10b5-1 Arrangement Modified Non-Rule 10b5-1 Arrangement Modified [Flag] Ordinary shares Underlying Warrants Ordinary shares Underlying Warrants Ordinary shares Underlying Warrants Two Thousand and Nineteen Non Executive Director Equity Incentive Plan [Member] Two Thousand and Nineteen Non Executive Director Equity Incentive Plan [Member] 2019 Non-Executive Director Equity Incentive Plan [Member] Defined Benefit Plan Disclosure [Line Items] Leasehold Improvements [Member] Leasehold improvements [Member] Gain (Loss), Foreign Currency Transaction, before Tax Foreign exchange Gain (Loss), Foreign Currency Transaction, before Tax, Total (Gain)/Loss on foreign currency exchange rates Foreign currency transaction gain/(loss) Entity Address, Address Line Two Fair value measurement Fair Value Disclosures [Text Block] Warrant liability. Warrant Liability [Text Block] Warrant liability UNITED STATES United States Warrants and Rights Note Disclosure [Abstract] Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses Other current liabilities Other Liabilities Disclosure [Text Block] Two Thousand And Twenty Warrants [Member] Two Thousand And Twenty Warrants Member Two Thousand And Twenty Warrants Plan Name [Domain] Lessee, Operating Lease, Liability, to be Paid, Next Rolling 12 Months 2025 Interest Expense Interest expense Interest Expense, Total Interest expense Contingent Consideration [Member] Contingent Consideration [Member] Contingent consideration Entity [Domain] Debt Instrument, Consideration, Liability Derecognised Debt Instrument, Consideration, Liability Derecognised Carrying Value of Debt Instrument Derecognised Research & Development Tax losses for Alternative Minimum Tax Research & Development Tax Losses for Alternative Minimum Tax Class Of Warrants Axis Class Of Warrants Axis Accrued Income Taxes Accrued local taxes Accrued Income Taxes, Total Related Party, Type [Axis] Class of Warrant or Right [Table] Entity Address, City or Town Other Commitments [Axis] Contingent Value Rights [Member] Contingent Value Rights [Member] Contingent Value Rights Security Exchange Name Long-Term Debt, Gross Carrying Value of Debt Instrument Loan Notes with a carrying value Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Other Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property and equipment, at cost Property and equipment, at cost Non Cash Conversion, Shares Non Cash Conversion, Shares Derivative liability. Derivative Liability [Text Block] Warrant Liability Intangible Assets Disclosure [Text Block] Intangible assets Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Net loss before income tax Net loss before income tax Expire In 2023 [Member] Expire In 2023 [Member] Unvested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Stock Issued During Period, Value, Performance Share Unit, Vesting Stock Issued During Period, Value, Performance Share Unit, Vesting Vesting of PSUs, value Unvested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value Antidilutive Securities, Name [Domain] Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Foreign rate differential Temporary Equity, Other Disclosure [Abstract] Cost Deferred Tax Assets, Goodwill and Intangible Assets Intangible fixed assets Intangible fixed assets Interest Paid, Excluding Capitalized Interest, Operating Activity Cash paid for interest Statistical Measurement [Domain] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net, Total Transfers of financial instruments Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise Price of Warrants Issued Assets, Current Total current assets Classes Of Share Capital Domain Classes Of Share Capital Domain Document Period End Date Other Income and Expenses [Abstract] Fair Value Hierarchy and NAV [Domain] Statement of Financial Position [Abstract] Restricted stock units Restricted Stock Units (RSUs) [Member] Restricted Stock Units [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Vesting [Axis] Deferred Tax Liabilities, Net Net deferred tax liabilities Net deferred tax liabilities Cost of revenue Cost of revenues Cost of revenues Cost of revenue Current Income Tax Expense (Benefit) Total current tax expense/(credit) Total current tax expense/(credit) Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Enacted Statutory Rate Effect of rate change on opening tax balances Liabilities Total liabilities Income (Loss) Attributable to Parent, before Tax Income before Income Taxes Income (Loss) Attributable to Parent, before Tax, Total Description Of Expected Volatility Share Options Granted Description Of Expected Volatility Share Options Granted Expected volatility (%) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Weighted average recognition term Amortization Expense Amortization Expense Prepaid Expense and Other Assets, Current [Abstract] Finite-Lived Intangible Assets, Gross Gross intangible assets Inangible asset, gross Amortizable intangible assets Weighted Average Number of Shares Outstanding, Diluted Weighted average shares outstanding - diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted-average number of shares used in computing net loss per share - diluted Entity File Number Cover [Abstract] Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of shares authorized Sale of Stock [Domain] Segment information Segment Reporting Disclosure [Text Block] General and Administrative Expense General and administrative General and Administrative Expense, Total General and administrative General and administrative expenses Description Of Risk Free Interest Rate Share Options Granted Description Of Risk Free Interest Rate Share Options Granted Risk-free interest rate (%) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Vested Vested Subsequent Event [Table] Disclosures on the fair value change in derivative liabilities. Disclosures on the Fair Value Change in Derivative Liabilities [Table Text Block] Schedule on the Fair Value Change in Derivative Liabilities Deferred Tax Assets, Other Others Others Intangible assets, net Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Net, Ending Balance Finite-Lived Intangible Assets, Net, Beginning Balance Intangible assets, net Debt Instrument, Convertible, Conversion Price Conversion Price Per Share CMOs [Member] Contract Manufacturing Organizations [Member] Contract Manufacturing Organizations [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested Vested Price Per Option Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Weighted Average Remaining Lease Term and Discount Rate Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Unit Activity and Related Information Stock Issued During Period, Shares, Conversion of Convertible Securities Conversion of convertible loan notes, shares Components Of Equity Domain Components Of Equity Domain Depreciation Depreciation Depreciation, Total Two Thousands and Nineteen Non-Executive Director Equity Incentive Plan [Member] Two Thousands and Nineteen Equity Incentive Plan [Member] 2019 EIP Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments Expected dividends (%) Common Stock, Shares, Outstanding Ending balance, shares Beginning balance, shares Ordinery stock, shares outstanding Operating Lease, Liability, Current Operating lease liabilities - current Lease liability - current Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Document Transition Report Valuation Allowance, Deferred Tax Asset, Change in Tax Rates Valuation Allowance, Deferred Tax Asset, Change in Tax Rates Change in tax rates Deferred Tax Assets, Net Total deferred tax, net Total deferred tax, net Total deferred tax, net Total deferred tax, net Research and Development Expense Research and development Research and Development Expense, Total Research and development Research and development expenses Stock Issued During Period Values Restricted Stock Award Gross Stock Issued During Period Values Restricted Stock Award Gross Delivery of shares on vesting of restricted stock units, value Cost of revenue Cost of Revenue, Total Cost of Revenue Cost of revenue Accrued cost of revenue Lessee, Operating Leases [Text Block] Leases Revenue Recognition and Deferred Revenue [Abstract] Revenue and Cost of revenue Statement of Cash Flows [Abstract] Applicable Tax Rate Applicable Tax Rate Applicable Tax Rate Issuance of shares, net of discount, value Stock Issued During Period, Value, New Issues Transfer between reserves Transfer between reserves Transfer between reserves Equity [Text Block] Shareholders' Equity Transaction costs on issuance of shares Transaction costs on issuance of shares Transaction costs on issuance of shares Finite-Lived Intangible Assets [Line Items] Earnings Per Share [Text Block] Loss Per Share Net loss Net loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Ending Balance Aggregate Intrinsic Value, Beginning Balance Aggregate intrinsic value Partner Type of Partners' Capital Account, Name [Domain] Equity issuance costs payable Equity Issuance Costs Payable Current Equity Issuance Costs Payable Current Other Nonoperating Income Mentmilestone payment received Fair Value Changes during The Year Fair Value Changes during The Year Changes in fair value during the period Deferred Tax Liabilities, Depreciation Deferred Tax Liabilities, Depreciation Depreciation Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividends (%) Accrual for Taxes Other than Income Taxes, Current Social security and other taxes Mereo Bio Pharma [Member] Mereo Bio Pharma [Member] Operating Lease, Payments Operating cash flows from operating leases Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Aggregate intrinsic value, Ending Balance Aggregate intrinsic value, Beginning Balance Assets [Abstract] Assets Partner Type [Axis] Proceeds Received From Broker And Settled Its Liability Proceeds Received From Broker And Settled Its Liability Proceeds Received From Broker And Setled Its Liability Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate (%) Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Deferred Tax Assets, Loan Relationships Deferred Tax Assets, Loan Relationships Loan relationships Loan relationships Document Fiscal Year Focus Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Share Based Compensation Arrangement by Share Based Payment Award Options, Vested, Shares Share Based Compensation Arrangement by Share Based Payment Award Options, Vested, Shares Vested Accounting Standards Update and Change in Accounting Principle [Abstract] Research Tax Credit Carryforward [Member] Research and Development Tax Credit Carryforward [Member] Restructuring Cost and Reserve [Line Items] Delivery of Shares on Vesting of Performance Based Restricted Stock Units Delivery of Shares on Vesting of Performance Based Restricted Stock Units Delivery of shares on vesting of performance based restricted stock units Other current liabilities Other Liabilities Other Liabilities, Total Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest and Granted Exercisable Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest and Granted Exercisable Aggregate Intrinsic Value Granted Collaboration And Licensing Agreement [Member] Collaboration And Licensing Agreement [Member] Collaboration And Licensing Agreement Issuance Of Ordinary Shares Issuance Of Ordinary Shares Issuance Of Ordinary Shares Expire In 2027 [Member] Expire In 2027 [Member] Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Novartis [Member] Novartis [Member] Novartis Deferred Tax Liabilities, Intangible Assets Intangible assets Increase (decrease) in research and development taxes receivable. Increase (Decrease) in Research and Development Taxes Receivable Research and development incentives receivable Sale of Stock [Axis] Revenues Revenue Revenues, Total Less: Present value discount Lessee Operating Lease Liability Undiscounted Adjustment Amount Lessee operating lease liability undiscounted adjustment amount. Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Private Placement [Member] Private Placement Warrants Private Placement Loan Notes Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] Deferred Tax Liabilities, Net [Abstract] Deferred tax liabilities: Conversion of convertible loan notes, value Stock Issued During Period, Value, Conversion of Units Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited Related Party, Type [Domain] Amount Commited to Acquire Intellectual Property Rights Amount Commited to Acquire Intellectual Property Rights Maximum amount Income Tax Disclosure [Text Block] Income Taxes Collaborative Arrangement and Arrangement Other than Collaborative [Table] Components Of Equity Axis Components Of Equity Axis Class of Warrant or Right [Line Items] Document Information [Table] Other Liabilities, Noncurrent Other non-current liabilities Tax Rate Effect Of Deferred Tax Assets And Liability Tax Rate Effect Of Deferred Tax Assets And Liability Tax Rate Effect Of Deferred Tax Assets And Liability Legal Entity [Axis] Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Property, Plant and Equipment [Table Text Block] Summary of Property and equipment, net Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price, Ending Balance Weighted Average Exercise Price, Beginning Balance Income Tax Disclosure [Abstract] Unrecognized Tax Benefits Unrecognized Tax Benefits, Ending Balance Unrecognized Tax Benefits, Beginning Balance Uncertain Tax Position Additional Paid-in Capital Additional Paid-in Capital [Member] Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other liabilities UNITED KINGDOM United Kingdom Measurement Frequency [Domain] Statement of Income Location, Balance [Axis] Convertible Loan Notes Text Block Convertible Loan Notes Text Block Convertible loan notes and equity classified warrants Trading Symbol Property, Plant and Equipment Disclosure [Text Block] Property and Equipment , net Going Concern Policy Text Block Going Concern [Policy Text Block] Going concern Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments, Total Conversion of convertible loan notes Subsequent Event Type [Axis] Effective Income Tax Rate Reconciliation, Change on Current and Deferred Taxes, Percent Effective Income Tax Rate Reconciliation, Change on Current and Deferred Taxes, Percent Effect of rate change on current and deferred taxes Warrant Liability Member Warrant Liability Member Warrant Liability Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected life (years) Fair Value, Recurring [Member] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued expenses Entity Ex Transition Period Total undiscounted payments Lessee, Operating Lease, Liability, to be Paid Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent U.K. R&D tax credits Equity Components [Axis] Equity Component [Domain] Previous Share Option Plans [Member] Previous Share Option Plans [Member] Previous Share Option Plans [Member] Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Abstract Business Combination [Axis] Ordinary Shares [Member] Ordinary Shares Member Ordinary Shares AstraZeneca [Member] AstraZeneca [Member] AstraZeneca [Member] Maximum [Member] Maximum IT equipment. IT Equipment [Member] IT equipment Statistical Measurement [Axis] ADSs Autonomous Decentralized Service System (Member) Autonomous Decentralized Service System Member Common Stock, Value, Issued Ordinary shares, par value 0.003 per share; 795,484,404 shares issued at September 30, 2025 (December 31, 2024: 775,728,034) Prepaid insurance premiums Prepaid Insurance Premiums Prepaid Insurance Premiums Pre-acquisition loss carryforward limit Pre Acquisition Loss Carryforward Limit Pre-acquisition loss carryforward limit Prepaid expenses and other current assets Prepaid expenses and other current assets [Text Block] Prepaid Expenses and Other Current Assets Related Party Transaction, Amounts of Transaction Related Party Transaction Convertible Notes Payable, Current Convertible loan notes - current Deferred Tax Assets, Operating Loss Carryforwards Operating losses carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Operating losses carryforwards Tax Credit Carryforward [Axis] Schedule of Weighted Average Number of Shares [Table Text Block] Schedule of Weighted Average Number of Ordinary Shares Outstanding and The Effect of Dilutive Ordinary Share Accrued Liabilities Total Bank Loan [Member] Bank Loan Member Bank Loan Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility (%) Finite-Lived Intangible Assets by Major Class [Axis] Deferred Tax Assets, Tangible Fixed Assets Deferred Tax Assets, Tangible Fixed Assets Tangible fixed assets Tangible fixed assets Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Employee Stock [Member] Employee Share Options [Member] Revenue from Contract with Customer [Text Block] Revenue and Cost of Revenue Entity Registrant Name Other Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Additional Paid in Capital Additional paid-in capital Additional Paid in Capital, Total Subsequent Events [Abstract] Income Tax Expense (Benefit) Income tax benefit Income Tax Expense (Benefit), Total Total income tax expense/(credit) Income tax benefit Total income tax expense/(credit) Measurement Frequency [Axis] Undiscounted [Member] Undiscounted [Member] Proceeds from Issuance of Common Stock Proceeds from issuance of ordinary shares Business Combination, Contingent Consideration, Type [Axis] Costs and Expenses [Abstract] Operating expenses Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Entity Common Stock, Shares Outstanding Other Income and Other Expense Disclosure [Text Block] Other Income/(expenses) , Net Stockholders' Equity, Period Increase (Decrease) Stockholders' Equity, Period Increase (Decrease), Total Issuance of ordinary shares, value Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Consolidation Items [Axis] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Purchase of property and equipment Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Accumulated Other Comprehensive Loss Income Member Accumulated Other Comprehensive Loss Income Member Accumulated Other Comprehensive Loss Gain (Loss), Foreign Currency Transaction, after Tax Gain (Loss), Foreign Currency Transaction, after Tax, Total Foreign currency transaction gain/(loss), net Assets Total assets Finite-Lived Intangible Assets, Net [Abstract] Property, Plant and Equipment [Table] Income Statement [Abstract] Schedule of Restructuring and Related Costs [Table] Current portion of research and development incentives receivables. Research and Development Incentives Receivables Current Research and development incentives receivables Deferred Income Tax Expense (Benefit) Total deferred tax expense Deferred Income Tax Expense (Benefit), Total Proceeds from Out-licensing Proceeds from out-licensing. Proceeds from out-licensing Other income Other Operating Income Issuance of shares, net of discount, shares Stock Issued During Period, Shares, New Issues Shares issued for upfront payment AstraZeneca milestones potentially payable in equity Milestones [Member] Milestones [Member] Etigilimab (MPH-313) [Member] Etigilimab (MPH-313) [Member] Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Interest expenses. Non-cash interest expense Interest Expenses Earnings Per Share, Diluted Loss per share - diluted Earnings Per Share, Diluted, Total Net loss per share - diluted Schedule of Financial Data for the Company's Reportable Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Operating Segments [Member] Amended AZ license agreement [Member] Amended Astra Zeneca License Agreement [Member] Amended Astra Zeneca License Agreement [Member] Title of 12(g) Security City Area Code Due From Related Party Due From Related Party Due from related party Disclosure Of Weighted Average Inputs To The Models Used For The Fair Value Of Warrants Granted Explanatory Disclosure Of Weighted Average Inputs To The Models Used For The Fair Value Of Warrants Granted Explanatory Shedule Of Weighted Average Inputs To The Models Used For The Fair Value Of Warrants Granted Explanatory Other Comprehensive Income (Loss), Net of Tax Foreign currency translation adjustments Other Comprehensive Income (Loss), Net of Tax, Total Lease Agreements [Member] Lease period extension Two Thousand Twenty Three Novartis Warrants [Member] Two Thousand Twenty Three Novartis Warrants [Member] 2023 Novartis Warrants Defined Benefit Plan [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested Vested Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining contractual lease term (years) Segment Reporting Information [Line Items] Delivery of shares on vesting of restricted stock units, shares Stock Issued During Period, Shares, Restricted Stock Award, Gross Vesting of RSUs, shares Lease expiration date Lease Expiration Date Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash and cash equivalents at January 1, Cash and cash equivalents at March 31, Operating Income (Loss) Loss from operations Loss from operations Accumulated Deficit Retained Earnings [Member] Entity Address, Country Business Combination, Contingent Consideration, Type [Domain] Warrants Classified In Equity [Member] Warrants Classified In Equity [Member] Warrants classified in equity Cash and Cash Equivalents [Axis] Intangible Assets, Current Intangible assets Employee Benefits and Share-Based Compensation Total Share-Based Payment Arrangement, Noncash Expense Share-based compensation Share-Based Payment Arrangement, Noncash Expense, Total Stock-based compensation Asset Acquisition, Consideration Transferred Asset acquisition Asset Acquisition, Consideration Transferred, Total Transaction costs on issuance of shares Incurred stock issuance costs Transaction costs on issuance of ordinary shares Transaction costs on issuance of shares Payments of Stock Issuance Costs License Agreement. License Agreement [Member] License Agreement [Member] Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate Operating Lease, Liability, Noncurrent Lease liability - non current Operating lease liabilities- non-current Fair Value, Inputs, Level 1 [Member] Level 1 Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Lease, Cost [Table Text Block] Schedule of Maturities of Operating lease liabilities Deferred Considerations Liability Current Deferred Considerations Liability Current Deferred Considerations Liability Current Nonoperating Income (Expense) [Abstract] Other income/(expenses) Derivative Liability, Noncurrent Warrant liabilities - non-current Benefit from Research and Development Tax Credit Benefit from Research and Development Tax Credit Benefit from research and development tax credit Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Potentially Dilutive Shares Were Not Included In The Calculation of Diluted Shares Outstanding. Income Tax Authority [Domain] Entity Interactive Data Current Statement of Income Location, Balance [Domain] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities Options Plan [Member] Options Plan [Member] Options Plan [Member] Two Thousands and Nineteen NED Equity Incentive Plan [Member] Two Thousands and Nineteen NED Equity Incentive Plan [Member] 2019 NED EIP Accounting Standards Update and Change in Accounting Principle [Text Block] Recent accounting pronouncements Entity Tax Identification Number Share Price Market value of ADSs Schedule of Common Stock Outstanding Roll Forward [Table Text Block] Summary of Common Shares Long-Term Debt, Type [Axis] Share Option Contractual Term Share Option Contractual Term Accrued Research and Development costs Accrued Research and Development costs Accrued research and development costs Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Effect of exchange rate changes Schedule of Stock Options Roll Forward [Table Text Block] Summary of Option Activity and Related Information Local Phone Number Related Party Transaction [Domain] Accumulated Tax Losses Carried Forward Accumulated Tax Losses Carried Forward Accumulated Tax Losses Carried Forward DRSUs Deferred Restricted Stock Units [Member] Deferred Restricted Stock Units [Member] Deferred Restricted Stock Units [Member] Exercise Price Per Warrants Exercise Price Per Warrants Exercise Price Per Warrants Other Liabilities, Current Other current liabilities Total Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Options Aggregate Intrinsic Value Nonvested Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Options Aggregate Intrinsic Value Nonvested Unvested Accounting Policies [Abstract] Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Number of ordinary shares Milestone proceeds Revenue from Contract with Customer, Excluding Assessed Tax Revised total milestone payments Two Thousand And Fifteen Asset Purchase Agreement And Ultragenyx Collaboration And Licensing Agreement [Member] Two Thousand And Fifteen Asset Purchase Agreement And Ultragenyx Collaboration And Licensing Agreement [Member] 2015 asset purchase agreement under the collaboration and license agreement with Novartis Office Equipment [Member] Office equipment [Member] Accrued Professional Fees, Current Accrued legal and professional fees Accrued Bonuses Accrued bonus Stock, Class of Stock [Table] Entity Emerging Growth Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted average contractual life of options, vested Tax Credit Carryforward, Name [Domain]